NCT07073209 PENG vs Femoral Block for Hip Fracture Analgesia
| NCT ID | NCT07073209 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Hip Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 352 participants |
| Start Date | 2025-07-10 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 352 participants in total. It began in 2025-07-10 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block. The choice of block will be dictated by a randomized monthly schedule, and all participants presenting during each four-week period will receive the designated block. A sub-group analysis will be performed to determine any difference in efficacy in participants with intracapsular versus extracapsular fractures.
Eligibility Criteria
Inclusion Criteria: 1. Male or female ≥ 18 years of age. 2. ASA Classification 1-4 3. Documentation of a hip fracture diagnosis along with radiologic read indicating fracture location 4. Written, informed consent for analgesic peripheral block placement Exclusion Criteria: 1. Altered mental status to the extent that it limits ability to report pain score 2. Patient or health care proxy refusal of analgesic nerve block 3. Allergy to study medications or contraindication to peripheral nerve block 4. Peri-prosthetic fracture 5. Any additional fractures in a patient with a unilateral hip fracture
Contact & Investigator
Tiffany Tedore, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT07073209 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07073209 currently recruiting?
Yes, NCT07073209 is actively recruiting participants. Contact the research team at mls9004@med.cornell.edu for enrollment information.
Where is the NCT07073209 trial being conducted?
This trial is being conducted at Manhattan, United States.
Who is sponsoring the NCT07073209 clinical trial?
NCT07073209 is sponsored by Weill Medical College of Cornell University. The principal investigator is Tiffany Tedore, MD at Weill Medical College of Cornell University. The trial plans to enroll 352 participants.